Predicted to enable beta-catenin binding activity and protein-macromolecule adaptor activity. Predicted to be involved in several processes, including cytoskeleton organization; negative regulation of cellular component organization; and regulation of signal transduction. Predicted to be located in cell cortex; nucleus; and ruffle membrane. Predicted to be active in cytoplasm and cytoskeleton. Human ortholog(s) of this gene implicated in spastic quadriplegic cerebral palsy 2. Orthologous to human KANK1 (KN motif and ankyrin repeat domains 1).
RGD Description
Predicted to enable beta-catenin binding activity and protein-macromolecule adaptor activity. Predicted to be involved in several processes, including cytoskeleton organization; negative regulation of cellular component organization; and regulation of signal transduction. Predicted to be located in cell cortex; nucleus; and ruffle membrane. Predicted to be active in cytoplasm and cytoskeleton. Human ortholog(s) of this gene implicated in spastic quadriplegic cerebral palsy 2. Orthologous to human KANK1 (KN motif and ankyrin repeat domains 1); INTERACTS WITH 1-naphthyl isothiocyanate; 2,3,7,8-tetrachlorodibenzodioxine; 4,4'-diaminodiphenylmethane.